Public Citizen Accuses Pfizer of Building ‘Paxlovid Patent Wall,’ Pfizer Pushes Back Post author:PacConAdmin Post published:February 18, 2022 Post category:Drug Industry Daily The advocacy group Public Citizen is accusing Pfizer of building a “Paxlovid patent wall.” Source: Drug Industry Daily You Might Also Like CBER Director Touts PDUFA Progress, Therapeutic Firsts in Fiscal 2017 January 5, 2018 FDA Finalizes Guidance on Chronic Rhinosinusitis With Nasal Polyps Drug Trials June 29, 2023 China Revises List of Reimbursed Drugs, Adds Over 300 Therapies February 23, 2017